Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Promising novel agents in AML: menin inhibitors
01:13
|
Download MP3
Related Videos
5:11
iStopMM: the psychological effects of MGUS screening and changes to clinical presentation of myeloma
3:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
1:31
Frontline treatment for CLL: the changing paradigm
1:42
The future of CLL treatment: aiming for long-lasting remission
5:21
Challenges in the treatment and management of ET and the need to improve therapeutic approaches
0:44
Early detection and interception across hematological cancers
1:36
The use of outpatient cilta-cel in the treatment of multiple myeloma
2:59
The tests that are needed to make a definitive diagnosis of CLL
1:01
Treatment-free remission after second-generation TKI treatment in CML
0:47
Advice for physicians when managing bispecific antibody treatment for patients with myeloma
3:02
The role of asparaginase in the treatment of ALL
1:56
Defining success in CLL
2:55
A model including CD49d expression to predict outcomes in patients with CLL treated with ibrutinib
6:54
Biomarker-guided treatment of CLL in the chemo-free era
1:53
CLL highlights from ASH 2023: the FLAIR study
2:00
Areas of research currently being explored for ultra-high-risk multiple myeloma
3:11
Defining and identifying ultra-high-risk multiple myeloma
2:13
Personalizing the timing of SCT in patients with myelofibrosis
2:17
Key challenges in treating patients with t(11;14) multiple myeloma with BCL2 inhibitors
1:17
Frailty-adapted therapy in myeloma: session takeaways
5:11 3:08 1:31 1:42 5:21 0:44 1:36 2:59 1:01 0:47 3:02 1:56 2:55 6:54 1:53 2:00 3:11 2:13 2:17 1:17
